Ajay Sudan
- Colorectal Cancer Treatments and Studies
- Radiomics and Machine Learning in Medical Imaging
- Cancer Treatment and Pharmacology
- Medical Imaging Techniques and Applications
- Pharmacological Effects and Toxicity Studies
- Epilepsy research and treatment
- Lung Cancer Treatments and Mutations
- Metabolism and Genetic Disorders
- Neonatal and fetal brain pathology
- Gastric Cancer Management and Outcomes
- Boron Compounds in Chemistry
Newcastle upon Tyne Hospitals NHS Foundation Trust
2023
St James's University Hospital
2023
Wellcome Trust
2023
Royal Manchester Children's Hospital
2013-2019
<p>Scatterplot: AREG vs EREG</p>
<p>Example AREG and EREG immunohistochemistry</p>
<p>Supplementary methods</p>
<p>Scatterplot: AREG vs EREG</p>
<p>Example AREG and EREG immunohistochemistry</p>
<p>Study flow diagram</p>
<p>Supplementary methods</p>
<p>Study flow diagram</p>
<div>Abstract<p>Purpose: High tumor production of the EGFR ligands, amphiregulin (AREG) and epiregulin (EREG), predicted benefit from anti-EGFR therapy for metastatic colorectal cancer (mCRC) in a retrospective analysis clinical trial data. Here, AREG/EREG immunohistochemistry (IHC) was analyzed cohort patients who received as part routine care, including key contexts not investigated previous analysis. Experimental Design: Patients panitumumab or cetuximab ± chemotherapy...
<p>Example AREG and EREG immunohistochemistry</p>
<p>Supplementary methods</p>